BRIEF-Biorestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data

Reuters11-13 21:09

Nov 13 (Reuters) - BioRestorative Therapies Inc

* BIORESTORATIVE THERAPIES REPORTS POSITIVE PRELIMINARY PHASE 2 BRTX-100 CLINICAL DATA

* BIORESTORATIVE THERAPIES INC - PATIENT REPORTED EFFICACY OUTCOMES SHOW A MATERIAL DECREASE IN PAIN AND INCREASE IN FUNCTION

* BIORESTORATIVE THERAPIES INC - CONFIDENT THAT PHASE 2 TRIAL WILL MEET ITS PRIMARY AND SECONDARY END POINTS

* BIORESTORATIVE THERAPIES INC - BLINDED PRELIMINARY DATA DEMONSTRATE A POSITIVE TREND AND CLEAR SIGNAL IN PRIMARY AND SECONDARY ENDPOINTS

Source text: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483400731?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-13 21:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483400731","market":"us","top_or_hot":-1,"title":"BRIEF-Biorestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data","media":"Reuters","content":"<html><body><p>Nov 13 (Reuters) - BioRestorative Therapies Inc</p><p> :</p><p>   * BIORESTORATIVE THERAPIES REPORTS POSITIVE PRELIMINARY PHASE 2 BRTX-100 CLINICAL DATA</p><p>   * BIORESTORATIVE THERAPIES INC - PATIENT REPORTED EFFICACY OUTCOMES SHOW A MATERIAL DECREASE IN PAIN AND INCREASE IN FUNCTION</p><p>   * BIORESTORATIVE THERAPIES INC - CONFIDENT THAT PHASE 2 TRIAL WILL MEET ITS PRIMARY AND SECONDARY END POINTS</p><p>   * BIORESTORATIVE THERAPIES INC - BLINDED PRELIMINARY DATA DEMONSTRATE A POSITIVE TREND AND CLEAR SIGNAL IN PRIMARY AND SECONDARY ENDPOINTS</p><p>Source text:   Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Biorestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Biorestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-13 21:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 13 (Reuters) - BioRestorative Therapies Inc :   * BIORESTORATIVE THERAPIES REPORTS POSITIVE PRELIMINARY PHASE 2 BRTX-100 CLINICAL DATA   * BIORESTORATIVE THERAPIES INC - PATIENT REPORTED EFFICACY ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BRTX","symbol_name":"BioRestorative Therapies, Inc.","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2483400731","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483400731","pubTimestamp":1731503340,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Nov 13  - BioRestorative Therapies Inc :   * BIORESTORATIVE THERAPIES REPORTS POSITIVE PRELIMINARY PHASE 2 BRTX-100 CLINICAL DATA   * BIORESTORATIVE THERAPIES INC - PATIENT REPORTED EFFICACY OUTCOMES SHOW A MATERIAL DECREASE IN PAIN AND INCREASE IN FUNCTION   * BIORESTORATIVE THERAPIES INC - CONFIDENT THAT PHASE 2 TRIAL WILL MEET ITS PRIMARY AND SECONDARY END POINTS   * BIORESTORATIVE THERAPIES INC - BLINDED PRELIMINARY DATA DEMONSTRATE A POSITIVE TREND AND CLEAR SIGNAL IN PRIMARY AND SECONDARY ENDPOINTSSource text:   Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BRTX":"BioRestorative Therapies, Inc.","BK4139":"生物科技"},"translate_title":"BRIEF–Biorestorative Therapies报告积极的初步2期BRTX-100临床数据","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BRTX":1},"content_text":"Nov 13 (Reuters) - BioRestorative Therapies Inc :   * BIORESTORATIVE THERAPIES REPORTS POSITIVE PRELIMINARY PHASE 2 BRTX-100 CLINICAL DATA   * BIORESTORATIVE THERAPIES INC - PATIENT REPORTED EFFICACY OUTCOMES SHOW A MATERIAL DECREASE IN PAIN AND INCREASE IN FUNCTION   * BIORESTORATIVE THERAPIES INC - CONFIDENT THAT PHASE 2 TRIAL WILL MEET ITS PRIMARY AND SECONDARY END POINTS   * BIORESTORATIVE THERAPIES INC - BLINDED PRELIMINARY DATA DEMONSTRATE A POSITIVE TREND AND CLEAR SIGNAL IN PRIMARY AND SECONDARY ENDPOINTSSource text:   Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483400731"}